1266 studies found for:
Uterine Cancer: Clinical Trials
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Active, not recruiting |
Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma
|
||||
| 22 | Recruiting |
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
|
||||
| 23 | Completed |
Musicotherapy in the Reduction of Fatigue in Women With Breast or Gynecological Cancer Under Radiotherapy
|
||||
| 24 | Completed |
Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema
|
||||
| 25 | Active, not recruiting |
Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus
|
||||
| 26 | Active, not recruiting |
Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
|
||||
| 27 | Completed |
A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma
|
||||
| 28 | Recruiting |
Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life
|
||||
| 29 | Recruiting |
Image-Guided Gynecologic Brachytherapy
|
||||
| 30 | Completed |
Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus
|
||||
| 31 | Active, not recruiting |
Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer
|
||||
| 32 | Unknown † |
Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer
|
||||
| 33 | Completed |
Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
|
||||
| 34 | Completed |
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
|
||||
| 35 | Completed |
Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus
|
||||
| 36 | Terminated |
Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
|
||||
| 37 | Terminated |
Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
|
||||
| 38 | Recruiting |
Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management.
|
||||
| 39 | Completed |
Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma
|
||||
| 40 | Terminated |
Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
|
† Indicates status has not been verified in more than two years

